BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
To deliver on the broad opportunities presented by quantum technologies to reduce costs and save lives, quantum-enabled products and services will need to become integrated within our NHS. This mission will build on early UK successes in the development of products to revolutionise healthcare capabilities and pull these through to adoption, providing a firm foundation to grow the UK quantum medical device industry sector.
The mission will also generate a pipeline of next-generation technologies which harness quantum physics to deliver early-stage diagnoses and improved surgical outcomes, across areas such as dementia, epilepsy, cancer, cardiovascular disease, infectious diseases, as well as quantum for life sciences and social care.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Resonance Alliance Inc. | - | £100,000 | - |